These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 751765)

  • 1. [Evaluation of blood lysozyme activity in diffuse, medullary space-occupying carcinomatosis as compared to similar non-space-occupying forms].
    Furno F; Zanfei A; Locatelli F; Giovanelli E; Neretto G; Capaldi MT
    Clin Ter; 1978 Nov; 87(4):361-5. PubMed ID: 751765
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lysozyme and cytostatic therapy].
    Neretto G; Giovanelli E; Agricola R; Pellegrino S; Bruno F; Mangione M; Furno F
    Clin Ter; 1978 Dec; 87(5):465-73. PubMed ID: 737983
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum lysozyme (muramidase) activity in dogs with neoplastic disease.
    Feldman BF; Madewell BR; Miller RB
    Am J Vet Res; 1981 Aug; 42(8):1309-21. PubMed ID: 6794392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the serum lysozyme level as a further parameter for predicting hematological tolerance in patients treated with cytostatic chemotherapy. Study of 134 cases].
    Neretto G; Agricola R; Giovanelli E; Poccardi G; Pellerito R; Furno F; Martinetto P; Pellegrino S; Daglio C; Tondolo M
    Recenti Prog Med; 1980 Oct; 69(4):431-57. PubMed ID: 7006015
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum lysozyme activity in patients with breast cancer treated by mastectomy and radiation.
    Prokopowicz J; Merkiel K; Korenkiewicz A; Kiluk S
    Neoplasma; 1984; 31(4):491-6. PubMed ID: 6472522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diffuse, systemic bone marrow metastasis of cancer].
    Nishioka K; Kanetake Y; Imaeda T
    Rinsho Hoshasen; 1968 May; 13(5):334-46. PubMed ID: 5188498
    [No Abstract]   [Full Text] [Related]  

  • 7. Muramidase activity of bone marrow plasma. Studies in haematologically normal individuals and in granulocytopenic patients.
    Hansen NE; Karle H; Andersen V
    Acta Med Scand; 1969 May; 185(5):387-92. PubMed ID: 5808638
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-hematological picture of neoplasm metastasis to the bone marrow].
    Glezer GI
    Sov Med; 1971 Nov; 34(11):142-3. PubMed ID: 5160626
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lysozyme activity of the serum and organs of the rabbit].
    Iwahara S; Ishizeki C; Koshinuma K
    Igaku To Seibutsugaku; 1968 Jul; 77(1):5-7. PubMed ID: 5750383
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
    Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
    Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood lysozyme level and bone marrow granulocyte reserve].
    Pellerito R; Agricola R; Giovanelli E; Neretto G
    Arch Sci Med (Torino); 1978; 135(4):485-92. PubMed ID: 756713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Histological tumor type and bone marrow metastases of cancers of the breast].
    Soudah B; Stauch G; Spindler B; Nicolai U; Georgii A
    Verh Dtsch Ges Pathol; 1985; 69():338-41. PubMed ID: 4096114
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinico-hematological aspects in medullary metastases of non-lymphomatous solid tumors].
    Ricci P; Brini C; Rosti G; Savelli G; Martinelli G; Bazzocchi F; Tura S
    Recenti Prog Med; 1980 Aug; 69(2):200-9. PubMed ID: 7455323
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood monocytes and tumor-infiltrating macrophages in human breast cancer: differences in activation level as assessed by lysozyme content.
    Steele RJ; Eremin O; Brown M
    J Natl Cancer Inst; 1983 Nov; 71(5):941-5. PubMed ID: 6316013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma acid and alkaline phosphatase in patients with breast cancer.
    Nguyen M; Bonneterre J; Hecquet B; Desoize B; Demaille A
    Anticancer Res; 1991; 11(2):831-3. PubMed ID: 2064338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lysozyme as a marker of host resistance. II. Patients with malignant melanoma, hypernephroma or breast carcinoma.
    Currie GA
    Br J Cancer; 1976 Jun; 33(6):593-9. PubMed ID: 938609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The lysozyme metabolism in the human body (author's transl)].
    Prokopowicz D; KoĊ‚akowska R; Trippner M
    Przegl Lek; 1980; 37(9):663-6. PubMed ID: 6999555
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum muramidase in patients with neutropenia.
    Vietzke WM; Perillie PE; Finch SC
    Yale J Biol Med; 1972 Oct; 45(5):457-62. PubMed ID: 4635683
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serum and urine muramidase activity in acute and chronic leukemia].
    Senn HJ; Rhomberg WU
    Schweiz Med Wochenschr; 1970 Nov; 100(46):1993-5. PubMed ID: 5279363
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood and bone-marrow lysozyme in neutropenia: an attempt towards pathogenetic classification.
    Hansen NE; Karle H
    Br J Haematol; 1971 Sep; 21(3):261-70. PubMed ID: 5569524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.